The most probable number (MPN) bioburden test method can be a valuable tool for determining bioburden counts when the typical bioburden test methods are problematic on a particular product or when a ...
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
The Global Bioburden Testing Market has been growing steadily at a CAGR of 12-15% due to increasing regulatory requirements and the rising focus on product safety. The market size is influenced by ...
DUBLIN--(BUSINESS WIRE)--The "Bioburden Testing Market by Product, Test, Application, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The bioburden ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback